Skip to main content
Fig. 7 | Retrovirology

Fig. 7

From: Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants

Fig. 7

Binding of RPV and compound 26 in the NNRTI binding pocket. Using the crystal structure of RPV (maroon) in the NNRTI binding pocket as a template, 26 (green) was docked into the HIV-1 RT NNRTI binding pocket. The residues shown in blue are important contacts for the binding of RPV; RPV selects for mutations at these residues. The residues shown in orange are important for the interaction of DOR in the NNRTI binding pocket; DOR selects for mutations at these positions. The red circle shows where amine linker of RPV resides, which is a structural feature 26 lacks. Thus 26 fails to interact with main chain carbonyl of K101, suggesting that this interaction, made by RPV, is important. The purple circle highlights a hydrogen bond interaction between the pyrimidine of RPV and the main chain amide of K101, which 26 fails to make, presumably due to its lack of the amine linker. The red dashes also depict a hydrogen bond network between water and E138 and RPV and 11 of the RT p51 subunit

Back to article page